These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6431756)

  • 21. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320
    [No Abstract]   [Full Text] [Related]  

  • 22. Cannabis sativa L. (marijuana) IX: Lens aldose reductase inhibitory activity of marijuana flavone C-glycosides.
    Segelman AB; Segelman FP; Varma SD; Wagner H; Seligmann O
    J Pharm Sci; 1977 Sep; 66(9):1358-9. PubMed ID: 409835
    [No Abstract]   [Full Text] [Related]  

  • 23. Purification of aldose reductase from human placenta and stabilization of the inhibitor binding site.
    Vander Jagt DL; Stangebye LA; Hunsaker LA; Eaton RP; Sibbitt WL
    Biochem Pharmacol; 1988 Mar; 37(6):1051-6. PubMed ID: 3128293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors.
    Klopman G; Buyukbingol E
    Mol Pharmacol; 1988 Dec; 34(6):852-62. PubMed ID: 3143909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola.
    Iwu MM; Igboko OA; Okunji CO; Tempesta MS
    J Pharm Pharmacol; 1990 Apr; 42(4):290-2. PubMed ID: 1974302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4h-chromen ring system.
    Kador PF; Sharpless NE
    Biophys Chem; 1978 Mar; 8(1):81-5. PubMed ID: 417745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The medicinal chemistry of aldose reductase inhibitors.
    Humber LG
    Prog Med Chem; 1987; 24():299-343. PubMed ID: 3144023
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibitory effect of 7 agents on bovine testis aldose reductase].
    Liu C; Zhu X
    Zhongguo Zhong Yao Za Zhi; 1997 Jun; 22(6):372-3, inside back cover. PubMed ID: 11038893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kinetic mechanism of human placental aldose reductase and aldehyde reductase II.
    Bhatnagar A; Das B; Gavva SR; Cook PF; Srivastava SK
    Arch Biochem Biophys; 1988 Mar; 261(2):264-74. PubMed ID: 3128169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of aldose reductase inhibitors on the metabolism of cultured monkey kidney epithelial cells.
    Boot-Handford R; Heath H
    Biochem Pharmacol; 1981 Nov; 30(22):3065-9. PubMed ID: 6802136
    [No Abstract]   [Full Text] [Related]  

  • 32. Aldose reductase inhibition and the diabetic syndrome of limited joint mobility: implications for altered collagen hydration.
    Eaton RP
    Metabolism; 1986 Apr; 35(4 Suppl 1):119-21. PubMed ID: 3083203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of aldose reductase in human cataractous lens and placenta].
    Yoshida H; Miyata M
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1370-8. PubMed ID: 6818855
    [No Abstract]   [Full Text] [Related]  

  • 34. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldose reductase inhibitors: flavonoids, alkaloids, acetophenones, benzophenones, and spirohydantoins of chroman.
    Nakai N; Fujii Y; Kobashi K; Nomura K
    Arch Biochem Biophys; 1985 Jun; 239(2):491-6. PubMed ID: 2988452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid purification of human placental aldose reductase.
    Kador PF; Carper D; Kinoshita JH
    Anal Biochem; 1981 Jun; 114(1):53-8. PubMed ID: 6792949
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on antidiabetic agents. IX. A new aldose reductase inhibitor, AD-5467, and related 1,4-benzoxazine and 1,4-benzothiazine derivatives: synthesis and biological activity.
    Tawada H; Sugiyama Y; Ikeda H; Yamamoto Y; Meguro K
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1238-45. PubMed ID: 2118427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and aldose reductase-inhibitory activities of structural analogues of WF-3681, a novel aldose reductase inhibitor.
    Namiki T; Baba Y; Suzuki Y; Nishikawa M; Sawada K; Itoh Y; Oku T; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1404-14. PubMed ID: 3138031
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE; Lai CJ
    Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report.
    Culebras A; Alió J; Herrera JL; López-Fraile MI
    Arch Neurol; 1981 Feb; 38(2):133-4. PubMed ID: 6781454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.